W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® CONFORMABLE AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number CXA280005 |
Device Problem
Positioning Failure (1158)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/20/2023 |
Event Type
malfunction
|
Event Description
|
The following was reported to gore: on (b)(6) 2023, the patient underwent an endovascular procedure to treat an abdominal aortic aneurysm (aaa) utilizing a gore® excluder® conformable aaa endoprosthesis.Reportedly, the conformable aortic extender deployed sideways, there were no issues with deployment itself as it was deployed very fast, positioned well and angulation was used on it but the device infolded on itself.Physician was able to balloon it enough to get another aortic extender (pla) and recuff it.There was no obstruction but positioning was bad (positioning up to deployment looked fine) as there was little angulation in the aortic neck (the markers looked fine and appeared to be where they should have been, until deployment) with stabilization by a second pair of hands and calcification in the iliac but not where device was deployed.Patient is doing okay.
|
|
Manufacturer Narrative
|
H6: code c19 - a review of the manufacturing records indicated the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Manufacturer Narrative
|
Imaging evaluation summary: the images received cannot be used to perform a full imaging evaluation because they do not meet the dicom standard.The extent and accuracy of the observations and findings may be limited due to the completeness, format and/or quality of the images provided for review.Gore cannot guarantee the images provided are complete, accurate or lack alteration.Therefore, gore cannot guarantee all key findings have been captured or that the findings are accurate.The imaging evaluation performed by a clinical imaging specialist showed the following: one jpg submitted for evaluation.Image received via email with no patient identifier or date of acquisition in image.Image cannot be manipulated in anyway.Unable to confirm invagination (anatomical restriction) with available image.Engineering evaluation summary: engineering evaluated the returned device and found no evidence of a stretched inner member of the catheter, necking of the inner member of the catheter, and damage to the trailing end of the leading tip.There were no observations that could have identified the root cause for aortic extender being deployed ¿sideways¿.Engineering could not confirm ¿conformable aortic extender deployed sideways¿ with the available information.
|
|
Search Alerts/Recalls
|
|
|